COMP <GO>
JAZZ vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Jazz Pharmaceuticals plc (Ireland) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: JAZZ 3
— UNH 8
■ METRIC PARITY
LAST: $229.74 (+7.14%) • MKT CAP: $13.92B
options-implied-move
—
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
options-implied-move
7.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JAZZ VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JAZZ | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.70% | 12.38% | -17.08 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 9.61% | 6.25% | +3.36 | JAZZ | /fcf-yield <GO> |
| Operating Margin | -10.10% | 5.32% | -15.42 | UNH | /operating-margins <GO> |
| Net Profit Margin | -8.30% | 3.53% | -11.83 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 4.90% | 3.33% | +1.57 | JAZZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.97 | 3.09 | -1.12 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.0 | 55.1 | -8.10 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 0.33 | +0.76 | JAZZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 17.7x | +18.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.92B | $359.43B | -$345.51B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JAZZ REV | UNH REV | JAZZ GROSS % | UNH GROSS % | JAZZ FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.27B | $447.57B | — | 88.7% | $1.30B | $16.07B |
| FY 2024 | $4.07B | $400.28B | — | 88.3% | $1.36B | $20.70B |
| FY 2023 | $3.83B | $371.62B | — | 89.6% | $919.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JAZZ // BETA 1.09
UNH // BETA 0.33